Helen Albert

Research led by Charité Berlin and Stanford University shows small circular pieces of extrachromosomal (ec)DNA that promote cancer growth lose potency if encapsulated in micronuclei.

A genetic variant present in approximately 16% of individuals of African ancestry and virtually absent in those of European ancestry significantly increases risk for dilated cardiomyopathy.

London-based biotech IMU Biosciences will partner with the UK Biobank, Waters Corporation, and Ultima Genomics to create a detailed immune database of 80,000 individuals already participating in the biobank.

Clinical trials are generating increasingly large amounts of data, but companies are under immense pressure to complete trials quickly and under budget. Could agentic artificial intelligence (AI) be the answer to getting the right patient to the right trial in a timely fashion?

Results from a small pilot study show transcranial ultrasound stimulation, using low-intensity targeted sound waves, can improve delusions in people with schizophrenia or schizoaffective disorder.

Children born through assisted reproductive technology techniques such as frozen embryo transfer and intracytoplasmic sperm injection (ICSI) could

UBT251, the triple hormone-receptor agonist developed by United Biotechnology and licensed by Novo Nordisk for treatment of type 2 diabetes and

UBT251, United Biotechnology and Novo Nordisk's GLP-1 triple hormone-receptor agonist, has achieved good type 2 diabetes results at Phase II.

Research from Nanjing University in China shows that breast milk from mothers with postnatal depression contains three specific micro (mi)RNAs that

A Swiss early stage study has uncovered a cell-surface receptor, LILRB2, that is overexpressed on acute myeloid leukemia (AML) cells, and which blocks the activity of CAR T-cell therapy designed to treat this cancer.